Castle Biosciences, Inc. (CSTL)

NASDAQ: CSTL · Real-Time Price · USD

27.91

-0.26 (-0.92%)

At close: Mar 5, 2026, 4:00 PM EST

27.91

0.00 (0.00%)

After-hours: Mar 5, 2026, 4:10 PM EST

Castle Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	116.73	119.71	98.84	122.95	329.63
Short-Term Investments	182.78	173.42	144.26	135.68	-
Cash & Short-Term Investments	299.51	293.13	243.1	258.63	329.63
Cash Growth	2.17%	20.58%	-6.00%	-21.54%	-19.57%
Accounts Receivable	43.38	51.22	38.3	23.48	17.28
Inventory	10.25	8.14	7.94	3.98	2.02
Other Current Assets	7.96	7.67	6.29	6.21	4.81
Total Current Assets	361.1	360.15	295.64	292.29	353.74
Net Property, Plant & Equipment	112.24	62.71	37.74	26.5	16.88
Goodwill	99.57	106.23	117.34	126.35	88.92
Other Long-Term Assets	5.65	2.15	2.63	2.2	3.02
Total Assets	578.56	531.24	453.34	447.33	462.57
Accounts Payable	18.71	6.9	10.27	4.73	2.55
Accrued Expenses	47.22	40.55	36.26	29.62	21.16
Current Portion of Long-Term Debt	0.42	0.28	-	-	-
Current Portion of Leases	1.33	1.67	1.14	1.78	1.18
Other Current Liabilities	1	-	-	-	-
Total Current Liabilities	68.68	49.39	47.67	36.13	24.89
Long-Term Debt	9.64	9.75	-	-	-
Long-Term Leases	25.53	14.66	14.2	11.53	6.9
Other Long-Term Liabilities	3.84	1.61	0.21	0.52	19.05
Total Long-Term Liabilities	39.01	26.01	14.4	12.05	25.95
Total Liabilities	107.68	75.4	62.07	48.18	50.83
Common Stock	0.03	0.03	0.03	0.03	0.03
Additional Paid-in Capital	694.86	655.7	609.48	560.41	505.48
Accumulated Other Comprehensive Income	0.27	0.23	0.14	-0.38	-
Retained Earnings	-224.28	-200.13	-218.37	-160.91	-93.77
Shareholders' Equity	470.87	455.84	391.27	399.15	411.74
Total Liabilities & Equity	578.56	531.24	453.34	447.33	462.57
Total Debt	36.91	26.34	15.34	13.31	8.08
Net Cash (Debt)	262.59	266.79	227.76	245.32	321.55
Net Cash Growth	-1.57%	17.13%	-7.15%	-23.71%	-20.95%
Net Cash Per Share	9.06	9.12	8.50	9.42	12.79
Book Value	470.87	455.84	391.27	399.15	411.74
Book Value Per Share	16.24	15.58	14.60	15.32	16.38
Tangible Book Value	371.3	349.61	273.93	272.8	322.82
Tangible Book Value Per Share	12.81	11.95	10.22	10.47	12.84

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q